Provided by Tiger Trade Technology Pte. Ltd.

National Healthcare

168.33
-0.0100-0.01%
Post-market: 168.330.00000.00%16:04 EST
Volume:89.83K
Turnover:15.18M
Market Cap:2.61B
PE:25.96
High:171.64
Open:168.40
Low:167.56
Close:168.34
52wk High:171.64
52wk Low:89.14
Shares:15.52M
Float Shares:12.46M
Volume Ratio:1.46
T/O Rate:0.72%
Dividend:2.50
Dividend Rate:1.49%
EPS(TTM):6.48
EPS(LYR):6.53
ROE:10.12%
ROA:4.95%
PB:2.48
PE(LYR):25.78

Loading ...

National Healthcare Properties Announces Release Date for Fourth Quarter and Full Year 2025 Results

GlobeNewswire
·
Yesterday

New Hope (ASX:NHC) Might Have The Makings Of A Multi-Bagger

Simply Wall St.
·
Feb 05

Record Revenue Growth and Higher Dividend Might Change The Case For Investing In National HealthCare (NHC)

Simply Wall St.
·
Jan 26

National Healthcare Properties Announces Confidential Submission of Draft Registration Statement

GlobeNewswire
·
Jan 20

Garofalo Health Care Finalizes Acquisition of Casa di Cura Città di Roma

Reuters
·
Jan 19

National Healthcare Properties Appoints Scott Humphrey to Board of Directors

Reuters
·
Jan 13

New Hope Corporation Limited's (ASX:NHC) Earnings Are Not Doing Enough For Some Investors

Simply Wall St.
·
Jan 13

Press Release: National Healthcare Properties Announces Preferred Stock Dividends

Dow Jones
·
Dec 20, 2025

National HealthCare (NHC): Reassessing Valuation After Outperform Rating Reaffirmed Despite Recent Insider Share Sale

Simply Wall St.
·
Dec 20, 2025

National Healthcare Corporation Sr. VP Operations Timothy J. Shelly Reports Disposal of Common Shares

Reuters
·
Dec 19, 2025

NHC Foods Unit Intra Metal Trading Rebrands to NHC International

MT Newswires Live
·
Dec 16, 2025

National Healthcare Properties Secures $550 Million Senior Unsecured Credit Facility

Reuters
·
Dec 12, 2025

Livzon Pharmaceutical Group Secures Inclusion of Products in China’s National Reimbursement Drug List

Reuters
·
Dec 08, 2025

Xuanzhu Biopharmaceutical's Anjiuwei Included in 2025 NRDL

Reuters
·
Dec 08, 2025

Jiangsu Hengrui Medicine Drugs Added to China’s National Reimbursement Drug List

Reuters
·
Dec 07, 2025

CARsgen's Zevor-Cel Approved in China for Relapsed/Refractory Multiple Myeloma

Reuters
·
Dec 07, 2025

Akeso's Five Innovative Drugs Gain Full Inclusion in China's 2025 National Reimbursement Drug List

Reuters
·
Dec 07, 2025

Should Executive Changes and Insider Selling at National HealthCare (NHC) Prompt Investors to Reevaluate Their Outlook?

Simply Wall St.
·
Nov 30, 2025

How Technical Downtrend and New Production Forecasts at New Hope (ASX:NHC) Have Changed Its Investment Story

Simply Wall St.
·
Nov 29, 2025

A Fresh Look at New Hope (ASX:NHC) Valuation Following AGM Approvals and 2026 Production Update

Simply Wall St.
·
Nov 28, 2025